On 13 May 2022, the conformity assessment for the unique in vitro diagnostic medical device MAFTEST® developed by Inbiomotion was completed and the declaration of conformity was drawn up.
Read moreEl pasado mes de mayo tuvo lugar la sesión de cierre del proyecto europeo PROTEOblood, en el Instituto de Investigación contra la Leucemia Josep Carreras (IJC). Bajo la coordinación del Dr. Gaël R...
Read moreWith an estimated 1.4 million new cases and 375,000 deaths worldwide, prostate cancer was the second most frequent cancer and the fifth leading cause of cancer death among men in 2020 (1). Metastatic ...
Read moreA project led by Roni Wright, alumni of the Centre for Genomic Regulation (CRG) and currently at the International University of Catalonia (UIC Barcelona), is one of fifteen initiatives chosen in the ...
Read moreLa combinación de inteligencia artificial y tecnologías de aprendizaje automático permite augurar un futuro con diagnósticos más fiables y personalizados para tratar con mayor eficacia enfermedad...
Read moreInbiomotion SL, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I-III) breast cancer patients, announces the results of comparin...
Read moreVall d’Hebron Research Institute (VHIR), a world-leading healthcare institution where healthcare, research, innovation and education go hand in hand, and Oncoheroes Biosciences, a biotech company ex...
Read moreFoundation for Addie’s Research Joins Oncoheroes moving volasertib into a clinical trial to create more and better options for children fighting cancer.
Read moreAn international study involving the IBB-UAB has identified how the 20 different forms of the p53 protein, unique to elephants, are activated to increase sensitivity and response against carcinogenic ...
Read moreThe study, led by researchers from Hospital Clínic-IDIBAPS, analyzes the genetic variants associated with the risk of developing the cancer and should make it possible to reduce the number of unneces...
Read moreResearchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the ...
Read moreLa división de cáncer del grupo Signaling Lab de la Universidad del País Vasco, dirigida por Iker Badiola, profesor de la Facultad de Medicina y Enfermería de la UPV/EHU, en colaboración con el g...
Read more